Amphastar Pharmaceuticals Inc (AMPH)

SG&A Expense Growth

5.41%

Quarterly · Period ending:

AMPH logo

AMPH SG&A Expense Growth

Latest reported5.41%
AMPH Quarterly SG&A Growth (QoQ) (0.00% → 5.41%)
High-resolution chart · PNG

AMPH sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amphastar Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
5.4148%
11.9813%
-47.5202%
110.402%
-13.05%
19.262%
-1.9063%
6.8126%
-10.9794%
15.2063%
14.0601%
0.3263%
-7.736%
27.9006%
-3.9838%
6.565%
-12.5299%
22.4075%
-6.1258%
-16.2566%
-5.9421%
25.6321%
3.082%
-23.0727%
42.094%
0.422%
-1.8326%
-7.6274%
-20.8034%
18.635%
6.7664%
13.4736%
6.4942%
17.2258%
-19.1565%
-2.9573%
7.9036%
5.1091%
0.8435%
12.0667%
-11.7166%
22.0004%
-1.8324%
-20.1362%
-8.5522%
24.017%
2.3342%
10.2102%
23.2725%
-12.8227%
-15.5447%
42.6516%
-7.0473%
8.3823%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.